271 filings
8-K
AADI
Aadi Bioscience Inc
11 Dec 20
Aerpio Announces Statistically Significant Topline Results from
5:08pm
4
Orbimed Advisors LLC
10 Dec 20
Change in insider ownership
5:04pm
SC 13D/A
AADI
Aadi Bioscience Inc
23 Nov 20
Aerpio Pharmaceuticals / Satter Muneer A ownership change
12:00am
SC 13D/A
Orbimed Advisors LLC
12 Nov 20
Aerpio Pharmaceuticals / ORBIMED ADVISORS ownership change
5:15pm
10-Q
2020 Q3
AADI
Aadi Bioscience Inc
Quarterly report
10 Nov 20
8:32am
8-K
nf0qamnizp s141
10 Nov 20
Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update
8:11am
424B5
hj5nv
25 Sep 20
Prospectus supplement for primary offering
4:11pm
8-K
j48367 y6
12 Aug 20
Aerpio Reports Second Quarter 2020 Financial Results and Provides
8:11am
424B5
m5cmijc8m 0r2vff
5 Aug 20
Prospectus supplement for primary offering
7:30am
8-K
vrdfxr72ash luit
5 Aug 20
Regulation FD Disclosure
7:23am
4
t18k8
26 Jun 20
Aerpio Pharmaceuticals / Pravin Dugel ownership change
4:44pm
4
o93gkr62l7xiv
26 Jun 20
Aerpio Pharmaceuticals / Anupam Dalal ownership change
4:43pm
4
eu0lgj22 i3momgg
26 Jun 20
Aerpio Pharmaceuticals / Caley Castelein ownership change
4:42pm
4
8vfdf0vi9bei z9g
26 Jun 20
Aerpio Pharmaceuticals / Steven Prelack ownership change
4:42pm
4
i0bn7y1dgpi
26 Jun 20
Aerpio Pharmaceuticals / Cheryl Cohen ownership change
4:40pm
8-K
mlr6kvkh
25 Jun 20
Aerpio Announces Initiation of28-Day Phase 2 Razuprotafib Glaucoma Trial
8:56am
DEFA14A
dvc2xgdjty
8 Jun 20
Additional proxy soliciting materials
5:05pm
8-K
8g13zehqwbllw7apmr
28 May 20
Regulation FD Disclosure
9:12am
SC 13D/A
2p6gr
15 May 20
Aerpio Pharmaceuticals / Novartis Bioventures ownership change
6:05am